Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Cyclophosphamide and Fludarabine to Treat Lupus Nephritis
This study has been completed.
Study NCT00001676 Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999 Last Updated: March 3, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Glomerulonephritis
Lupus Nephritis
Systemic Lupus Erythematosus
Additional conditions recognized in this trial
Lupus Erythematosus, Systemic
Nephritis
More general conditions related to this trial
Autoimmune Diseases
Connective Tissue Diseases
Immune System Diseases
Kidney Diseases
Urologic Diseases
Interventions listed in this trial
SQ Fludarabine
Additional drug interventions recognized in this trial
Cyclophosphamide
Fludarabine
Fludarabine monophosphate
More general drug interventions related to this trial
Alkylating Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antirheumatic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Back to top of Main Content
